[ad_1] Verve Therapeutics Inc. shares VERV, -44.39% fell 40% premarket on Monday after the biotech…
development
-
-
STOCK MARKET
Novo Nordisk’s Wegovy cuts risk of heart attack and stroke by 20% among people without diabetes, study finds
by userby user[ad_1] Novo Nordisk’s popular weight-loss drug Wegovy significantly cut the risk of heart attack, stroke or…
-
[ad_1] In the era where innovation is the linchpin of staying competitive, the video game…
-
STOCK MARKET
Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait
by userby user[ad_1] Amgen Inc.’s stock fell 3.3% Tuesday to put it on track for its biggest…
-
[ad_1] Renowned as the “startup nation”, Israel’s vibrant technological ecosystem stands as a testament to…
-
STOCK MARKET
Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
by userby user[ad_1] Fixes story to correct spelling of analyst’s name. The trial success of Novo Nordisk’s…
-
STOCK MARKET
Amgen to continue to seek full approval of Lumakras cancer drug after FDA panel votes against it
by userby user[ad_1] Amgen Inc. said it would continue to work closely with the Food and Drug…
-
[ad_1] The U.S. Patent and Trademark Office’s patent trial and appeal board has agreed to…
-
[ad_1] Moderna Inc. announced positive interim results from a Phase 1/2 trial of its combination…
-
STOCK MARKET
Embattled Speaker McCarthy tries new 45-day funding tactic to avoid government shutdown
by userby user[ad_1] House Speaker Kevin McCarthy, with mere hours left before a federal government shutdown, tried a…